ARTICLE | Company News
Depomed sales and marketing update
November 4, 2013 8:00 AM UTC
Depomed launched Lazanda fentanyl nasal spray in the U.S. to manage pain and the Signature Support Program. Depomed said the Signature Support Program streamlines patient access to Lazanda and offers...